Accelerating Your New Therapies Path To Market With Automation

By Laura Acosta, VP of Product Management, eClinical Division

Automated digital solutions are becoming an essential tool to achieve faster clinical trial set-up and execution. The COVID-19 pandemic underscored the necessity for streamlined medical research and highlighted the inefficiencies in traditional clinical trial methodologies, such as lengthy patient recruitment and high dropout rates. Automation addresses these challenges by enhancing patient enrollment, site engagement, and various trial tasks, thereby improving overall efficiency.

Key automation benefits such as efficient candidate sorting, streamlined trial setup, and consistent digital workflows, enable clinical trial teams to concentrate on more critical tasks as well as patient care. AnjuEPS provides a suite of automated tools designed to accelerate early-phase trials. Learn about the features of this tool that collectively contribute to reducing the time to market for new therapies while ensuring security and compliance.